By Justin Leverenz, Chief Investment Officer, Developing Markets Equities China is unique among developing markets, not only ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

Brian Armstrong, the billionaire CEO of the cryptocurrency exchange Coinbase, says he’s ready to fund a US startup focused on ...

The investment bank says funding was down 57% last month, to $2.7 billion, and argues the new administration’s FDA ...

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...

China is now setting the pace in life sciences R&D, conducting more clinical trials than the U.S. and licensing new ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech ETFs, ...

CAMBRIDGE, Mass., May 20, 2025 /PRNewswire/ -- Alacrita, a leading life science consulting firm, has expanded its biotech investment and fundraising advisory services with the appointment of Lucas ...

Wise investors know that their funds’ sector weightings matter. Morningstar recognizes 11 equity sectors, including technology, healthcare, and industrials. But each sector comprises various ...